atropine has been researched along with pepstatin in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (pepstatin) | Trials (pepstatin) | Recent Studies (post-2010) (pepstatin) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 696 | 0 | 125 |
| Protein | Taxonomy | atropine (IC50) | pepstatin (IC50) |
|---|---|---|---|
| Pepsin A | Sus scrofa (pig) | 0.011 | |
| Renin | Homo sapiens (human) | 1.9333 | |
| Cathepsin D | Homo sapiens (human) | 0.3597 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Cathepsin B | Homo sapiens (human) | 4.26 | |
| Candidapepsin-2 | Candida albicans | 0.09 | |
| Pepsin A-5 | Homo sapiens (human) | 0.059 | |
| Cathepsin E | Homo sapiens (human) | 0.5558 | |
| Plasmepsin-1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0009 | |
| Plasmepsin-2 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0005 | |
| Cathepsin D | Bos taurus (cattle) | 0.0235 | |
| Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | 0.0563 | |
| Plasmepsin 4 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0003 | |
| Cysteine protease | Leishmania donovani | 0.16 | |
| Protease | Human immunodeficiency virus 1 | 0.947 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagase, K; Kobata, A; Kotani, T; Murashima, Y; Takeuchi, K | 1 |
1 other study(ies) available for atropine and pepstatin
| Article | Year |
|---|---|
Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury.
Topics: Animals; Anti-Ulcer Agents; Atropine; Cimetidine; Dose-Response Relationship, Drug; Male; Omeprazole; Pepsin A; Pepstatins; Pylorus; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2007 |